Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis-Reference-Cited by-同舟云学术

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis

Published:2015-03-06 Issue:3 Volume:9 Page:e0003557
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Baharia Rajendra K,Tandon Rati,Sharma Tanuj,Suthar Manish K,Das Sanchita,Siddiqi Mohammad Imran,Saxena Jitendra Kumar,Sunder Shyam,Dube Anuradha

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference70 articles.

1. Leishmaniasis;BL Herwaldt;Lancet,1999

2. Visceral Leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda;PJ Guerin;Lancet Infect Dis,2002

3. Serious underreporting of visceral Leishmaniasis through passive case reporting in Bihar;SP Singh;India. Trop Med Int Health,2006

4. Estimation of under-reporting of visceral Leishmaniasis cases in Bihar, India;VP Singh;Am J Trop Med Hyg,2010

5. Leishmaniasis: current situation and new perspectives;P Desjeux;Comp Immunol Microbiol Infect Dis,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis;Biology;2023-06-13

2. Vaccines for Canine Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

3. Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis;Cellular Immunology;2022-05

4. Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model;Molecular Immunology;2022-01

5. Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis;Parasite Immunology;2020-05-28